Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply

Saved in:

Bibliographic Details
Published in:	AIDS (London) Vol. 22; no. 4; pp. 548 - 549
Main Authors:	PHILLIPS, Elizabeth, HAYDEN, Anna, GUTIERREZ, Sonia, JAHNKE, Natalie, YIP, Benita, LIMA, Viviane D, HOGGG, Robert S, HARRIGAN, P. Richard, MONTANER, Julio S. G
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 19-02-2008
Subjects:	Anti-HIV Agents - adverse effects Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Drug Hypersensitivity - etiology Hepatitis C, Chronic - mortality HIV Infections - mortality Human viral diseases Humans Infectious diseases Medical sciences Nevirapine - adverse effects Pharmacology. Drug treatments Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis Human Antiretroviral agent RNA-directed DNA polymerase Mixed infection Prognosis Nevirapine Enzyme Non nucleoside compound Transferases Hypersensitivity Mortality Enzyme inhibitor Hepatic disease Infection Viral hepatitis A Nucleotidyltransferases Treatment Reverse transcriptase inhibitor Viral disease Digestive diseases Antiviral Viral hepatitis C
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0269-9370 1473-5571
DOI:	10.1097/QAD.0b013e3282f4a0ed